Ordaōs

Ordaōs is a drug asset foundry that creates value through an internal pipeline, external partnerships, and proprietary data generation. Its Design Engine is the powerful factory that generates novel biological entities with greater efficacy and safety than traditional methods. Ordaos leverages lab-in-the-loop generative AI to design proteins with the entirety of its AI system and its cell-free-protein-synthesis system developed in house. Ordaos’ in-house cell-free-protein-synthesis system yields 81X the material as commercially available CFPS systems and enables the production of proteins in hours, 100X faster than traditional cell-based protein production methods. With its Design Engine, Ordaos aims to accelerate the reduction of disease burden globally and bring 10 staggeringly effective therapies to patients in need in 10 years. 

—

Learn more at: ordaos.com